Radiation therapy for lymphoma is highly effective and safer than ever before, says Memorial Sloan Kettering radiation oncologist Joachim Yahalom. Doctors use sophisticated technologies such as IMRT (intensity-modulated radiation therapy) – many of them developed at Memorial Sloan Kettering – in combination with imaging techniques such as MRI, CT scan, and PET to deliver small, targeted doses of radiation precisely to the tumor site. Medical physicists work closely with radiation oncologists to plan treatment and ensure the highest level of safety throughout each patient’s treatment.
CHOP (cyclophosphamide, hydroxyodaunorubicin, Oncovin®, and prednisone) is the most widely used chemotherapy regimen for patients with non-Hodgkin lymphoma. Another regimen, called ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine), is commonly used to treat patients with Hodgkin lymphoma. Most people can function normally while using these chemotherapy regimens, although some side effects can occur.
Researchers are also in the process of developing novel, targeted therapies that may offer improved convenience and fewer side effects than these chemotherapy regimens.
Experts at Memorial Sloan Kettering emphasize the value of their team approach to diagnosing and treating lymphoma, with patients benefiting from the collective expertise of multiple experts who meet on a weekly basis to review each case.